Literature DB >> 3944162

Deep sepsis following total knee arthroplasty. Ten-year experience at the University of California at Los Angeles Medical Center.

T J Grogan, F Dorey, J Rollins, H C Amstutz.   

Abstract

Between September 1971 and May 1982, at the University of California at Los Angeles Medical Center, 821 total knee arthroplasties were performed in 604 patients, all of whom received perioperative antibiotics. Deep sepsis, proved by a positive culture of a specimen obtained by postoperative arthrocentesis, developed fourteen times in thirteen knees of twelve patients, an incidence of 1.71 per cent. In one of these patients, who had systemic lupus erythematosus and bilateral knee replacement, the right knee became infected with two distinct organisms on two different occasions (separated by ten months). The first infection was probably hematogenous while the second, developing after a dental procedure, definitely was. Over-all, five infections were hematogenous with an identified source and one other was suspected of having a hematogenous origin. The time from operation to the diagnosis of sepsis averaged 8.3 months over-all, but five of the fourteen infections were recognized less than two months after arthroplasty. For the six infections that were assumed to be hematogenous, the time from operation to the diagnosis of sepsis averaged 16.4 months. The major presenting symptom was pain in thirteen of the fourteen infections. The initial treatments of the fourteen infections consisted of intravenous antibiotics in all of them, primary removal of the prosthesis and so-called exchange arthroplasty after five days in one, removal of the prosthesis and fusion in one, arthrotomy and débridement in six, arthroscopic irrigation in three, and antibiotics alone in three (of which one was treated with an exchange arthroplasty after three weeks). At last follow-up, only four of the thirteen prostheses had been salvaged.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944162

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  23 in total

1.  Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: an open study.

Authors:  F de Lalla; R Viola; G Pellizzer; L Lazzarini; A Tramarin; P Fabris
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Assessing the gold standard: a review of 253 two-stage revisions for infected TKA.

Authors:  Tahir Mahmud; Matthew C Lyons; Douglas D Naudie; Steven J Macdonald; Richard W McCalden
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

Review 3.  Organic-inorganic composites for bone drug delivery.

Authors:  Chidambaram Soundrapandian; Biswanath Sa; Someswar Datta
Journal:  AAPS PharmSciTech       Date:  2009-10-20       Impact factor: 3.246

4.  The salvage of knee-exposed prosthesis using neurofasciocutaneous sural flap.

Authors:  L Vaienti; A Menozzi; J Lonigro; M Soresina; G Ravasio
Journal:  Musculoskelet Surg       Date:  2010-03-05

5.  Irrigation and débridement and prosthesis retention for treating acute periprosthetic infections.

Authors:  Jonathan P Van Kleunen; Denise Knox; Jonathan P Garino; Gwo-Chin Lee
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

6.  Antibiotic prophylaxis for haematogenous bacterial arthritis in patients with joint disease: a cost effectiveness analysis.

Authors:  P Krijnen; C J Kaandorp; E W Steyerberg; D van Schaardenburg; H J Moens; J D Habbema
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

7.  Late infection of total knee arthroplasty inflamed by anti-TNFalpha, Infliximab therapy in rheumatoid arthritis.

Authors:  Takashi Yurube; Koichiro Takahi; Hajime Owaki; Takeshi Fuji; Masahiro Kurosaka; Minoru Doita
Journal:  Rheumatol Int       Date:  2009-05-16       Impact factor: 2.631

8.  Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants.

Authors:  M Drancourt; A Stein; J N Argenson; A Zannier; G Curvale; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

9.  Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole).

Authors:  A Stein; J F Bataille; M Drancourt; G Curvale; J N Argenson; P Groulier; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Prophylactic use of antibiotic-loaded bone cement in primary total knee arthroplasty: Justified or not?

Authors:  Amit K Srivastav; Biren Nadkarni; Shekhar Srivastav; Vivek Mittal; Shekhar Agarwal
Journal:  Indian J Orthop       Date:  2009-07       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.